Last reviewed · How we verify

NCT05115851

Short Term Effects of Anodal Cerebellar vs Anodal Cerebral Transcranial Direct Current Stimulation in Stroke Patients

Completed NA Last updated 2 August 2023
What this trial tests

NA trial testing Anodal tDCS cerebellar stimulation group in Stroke in 66 participants. Completed in 30 June 2022.

Timeline
5 October 2021
Primary endpoint
30 June 2022
30 June 2022

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment66
Start date5 October 2021
Primary completion30 June 2022
Estimated completion30 June 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 60 to 80, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effect of anodal cerebellar Transcranial Direct Current Stimulation (tDCS) vs anodal cerebral tDCS on balance, mobility and cognition in stroke patients in stroke patients

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Short term effects of anodal cerebellar vs. anodal cerebral transcranial direct current stimulation in stroke patients, a randomized control trial.
    Qurat-Ul-Ain, Ahmad Z, Ishtiaq S, Ilyas S, et al · · 2022 · cited 12× · PMID 36507323 · DOI 10.3389/fnins.2022.1035558

Verify or expand the search:

Other trials of Anodal tDCS cerebellar stimulation group

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05115851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing